Helix Cbd Clinical (menthol recalls
The FDA has published 1 recall involving Helix Cbd Clinical (menthol since 2023. The latest was reported on 30 Aug 2023. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 30 Aug 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why helix cbd clinical (menthol is recalled
Companies
By year
All helix cbd clinical (menthol recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Helix CBD Clinical Cream (Menthol 7.4%) recalled by Parker Laboratories | Parker Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Helix Cbd Clinical (menthol?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.